These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21319202)

  • 21. Deciphering the nuclear bile acid receptor FXR paradigm.
    Modica S; Gadaleta RM; Moschetta A
    Nucl Recept Signal; 2010 Nov; 8():e005. PubMed ID: 21383957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caveolin-1 Function in Liver Physiology and Disease.
    Fernandez-Rojo MA; Ramm GA
    Trends Mol Med; 2016 Oct; 22(10):889-904. PubMed ID: 27633517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear bile acid receptor FXR in the hepatic regeneration.
    Chen WD; Wang YD; Meng Z; Zhang L; Huang W
    Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors.
    Shin DJ; Wang L
    Handb Exp Pharmacol; 2019; 256():51-72. PubMed ID: 31230143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolomic window into hepatobiliary disease.
    Beyoğlu D; Idle JR
    J Hepatol; 2013 Oct; 59(4):842-58. PubMed ID: 23714158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bile acid-mediated control of liver triglycerides.
    Fuchs C; Claudel T; Trauner M
    Semin Liver Dis; 2013 Nov; 33(4):330-42. PubMed ID: 24222091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice.
    Ji C; Kaplowitz N; Lau MY; Kao E; Petrovic LM; Lee AS
    Hepatology; 2011 Jul; 54(1):229-39. PubMed ID: 21503947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of bile acid metabolism in liver diseases.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Jan; 7(1):7-29. PubMed ID: 6281949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new therapeutic frontier--nuclear receptors and the liver.
    Karpen SJ; Trauner M
    J Hepatol; 2010 Mar; 52(3):455-62. PubMed ID: 20133000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease.
    Claudel T; Zollner G; Wagner M; Trauner M
    Biochim Biophys Acta; 2011 Aug; 1812(8):867-78. PubMed ID: 21194565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.
    Fuchs CD; Trauner M
    Nat Rev Gastroenterol Hepatol; 2022 Jul; 19(7):432-450. PubMed ID: 35165436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Farnesoid X receptor modulators (2011 - 2014): a patent review.
    Sepe V; Distrutti E; Fiorucci S; Zampella A
    Expert Opin Ther Pat; 2015; 25(8):885-96. PubMed ID: 26183029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatobiliary ABC transporters: physiology, regulation and implications for disease.
    Jonker JW; Stedman CA; Liddle C; Downes M
    Front Biosci (Landmark Ed); 2009 Jun; 14(13):4904-20. PubMed ID: 19482594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNAs: fad or future of liver disease.
    Lakner AM; Bonkovsky HL; Schrum LW
    World J Gastroenterol; 2011 May; 17(20):2536-42. PubMed ID: 21633658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of SHP-null mice to bile acid-induced liver damage.
    Wang L; Han Y; Kim CS; Lee YK; Moore DD
    J Biol Chem; 2003 Nov; 278(45):44475-81. PubMed ID: 12933814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of peroxisome proliferator-activated receptors in the regulation of bile acid metabolism.
    Sun Y; Zhang L; Jiang Z
    Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):315-324. PubMed ID: 38048777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aging and liver disease].
    Tanikawa K; Kamishiro R
    Nihon Ronen Igakkai Zasshi; 1993 Dec; 30(12):1026-31. PubMed ID: 8114338
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
    Ginsberg HN
    Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear receptor ligands in therapy of cholestatic liver disease.
    Sturm E; Wagner M; Trauner M
    Front Biosci (Landmark Ed); 2009 Jan; 14(11):4299-325. PubMed ID: 19273351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.